All In Biotech

Drug Trial Radar · NCT07223203

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

TRITON-PN: A Phase 3, Global, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy (hATTR-PN)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 125 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

125

Planned (sponsor's estimate)

Start

Feb 3, 2026

Primary completion

Dec 27, 2027

Study completion Jun 12, 2031

Sponsor

Lead sponsor
Alnylam PharmaceuticalsAlnylam Pharmaceuticals (ALNY)
Sponsor type
Industry
First posted
Oct 31, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to: * Determine the efficacy of nucresiran in patients with hATTR-PN by evaluating the effect on neurologic impairment, quality of life, nutritional status, disability, and gait speed * Demonstrate superiority of nucresiran compared to in-study vutrisiran with respect to serum transthyretin (TTR) levels

Conditions

  • Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
  • hATTR-PN

Interventions

  • NucresiranDrug

    Nucresiran 300 mg administered SC q6M

  • VutrisiranDrug

    Vutrisiran 25 mg administered SC q3M

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in the Modified Neuropathy Impairment Score +7 (mNIS+7) Compared to the External Placebo Group from the APOLLO Study (NCT01960348) at Month 9Time frame: Baseline and Month 9

Locations

61 sites in 22 countries. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Aurora, Colorado · Recruiting

  • Clinical Trial Site

    Chicago, Illinois · Recruiting

  • Clinical Trial Site

    Baltimore, Maryland · Recruiting

  • Clinical Trial Site

    Boston, Massachusetts · Recruiting

  • Clinical Trial Site

    Rochester, Minnesota · Recruiting

  • Clinical Trial Site

    New York, New York · Recruiting

  • Clinical Trial Site

    New York, New York · Recruiting

  • Clinical Trial Site

    Chapel Hill, North Carolina · Recruiting

  • Clinical Trial Site

    Nashville, Tennessee · Recruiting

  • Clinical Trial Site

    Dallas, Texas · Recruiting

  • Clinical Trial Site

    Houston, Texas · Recruiting

  • Clinical Trial Site

    Belgrano, Argentina · Recruiting

  • Clinical Trial Site

    Rosario, Argentina · Recruiting

  • Clinical Trial Site

    Darlinghurst, Australia · Recruiting

  • Clinical Trial Site

    Woolloongabba, Australia · Recruiting

  • Clinical Trial Site

    Ribeirão Preto, Brazil · Recruiting

  • Clinical Trial Site

    Rio de Janeiro, Brazil · Recruiting

  • Clinical Trial Site

    Rio de Janeiro, Brazil · Recruiting

  • Clinical Trial Site

    Salvador, Brazil · Recruiting

  • Clinical Trial Site

    São Paulo, Brazil · Recruiting

  • Clinical Trial Site

    Vancouver, Canada · Recruiting

  • Clinical Trial Site

    Égkomi, Cyprus · Recruiting

  • Clinical Trial Site

    Créteil, France · Recruiting

  • Clinical Trial Site

    Le Kremlin-Bicêtre, France · Recruiting

  • Clinical Trial Site

    Marseille, France · Recruiting

  • Clinical Trial Site

    Berlin, Germany · Recruiting

  • Clinical Trial Site

    Heidelberg, Germany · Recruiting

  • Clinical Trial Site

    Münster, Germany · Recruiting

  • Clinical Trial Site

    Athens, Greece · Recruiting

  • Clinical Trial Site

    Heraklion, Greece · Recruiting

  • Clinical Trial Site

    Dublin, Ireland · Recruiting

  • Clinical Trial Site

    Florence, Italy · Recruiting

  • Clinical Trial Site

    Milan, Italy · Recruiting

  • Clinical Trial Site

    Padova, Italy · Recruiting

  • Clinical Trial Site

    Pavia, Italy · Recruiting

  • Clinical Trial Site

    Roma, Italy · Recruiting

  • Clinical Trial Site

    Bunkyo C, Japan · Recruiting

  • Clinical Trial Site

    Kumamoto, Japan · Recruiting

  • Clinical Trial Site

    Matsumoto-shi, Japan · Recruiting

  • Clinical Trial Site

    Suita, Japan · Recruiting

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.